Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:53 PM
Ignite Modification Date: 2025-12-25 @ 1:19 PM
NCT ID: NCT00267059
Description: None
Frequency Threshold: 5
Time Frame: 3 years
Study: NCT00267059
Study Brief: Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Lenalidomide 10 mg/day, orally once a day for 28 days None None 24 44 34 44 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Pseudomonas Aeruginosa Bactremia SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (3.0) View
Infection SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (3.0) View
Pain SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (3.0) View
Death SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (3.0) View
Pneumocystis carinii pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (3.0) View
Mucormycosis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Fever of unknown origin SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (3.0) View
Hypertension SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE (3.0) View
Hypotension SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE (3.0) View
Diverticulitis SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (3.0) View
Rotavirus SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Tumor Flare SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Secondary Malignancy Lung SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) CTCAE (3.0) View
Viral Hepatitis Reactivation SYSTEMATIC_ASSESSMENT Immune system disorders CTCAE (3.0) View
Prostate Infection SYSTEMATIC_ASSESSMENT Infections and infestations CTCAE (3.0) View
Stroke SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE (3.0) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Hyperbilirubinemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (3.0) View
Thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (3.0) View
Pleural Effusion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (3.0) View
Criptosporididosis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (3.0) View
Thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (3.0) View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (3.0) View
Fatigue SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
Tumor Flare SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View